Punam Sandhu

Punam Sandhu, Ph.D., is currently serving as Vice President of Global Regulatory Strategy for Oncology and Specialty Medicine at Daiichi Sankyo US, a position held since April 2024. Prior to this role, Punam held various senior positions at Jazz Pharmaceuticals, including Head of Global Regulatory Strategy for Hematology/Oncology and Rare Diseases from November 2018 to April 2024. Punam's career at Merck from October 1998 to November 2018 included significant positions such as Senior Principal Scientist in Regulatory Affairs, focusing on oncology programs, and leading global regulatory submissions. Punam began the professional journey at SmithKline Beecham Corporation as an Investigator in Drug Metabolism & Pharmacokinetics. Academic credentials include a Ph.D. in Cancer Research from the University of Birmingham and a Post-Doctoral Research Fellowship in Molecular Toxicology from Vanderbilt University School of Medicine.